Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Metastatic Testicular Cancer"'
Autor:
Taisho Noda, Akira Fujisaki, Kosuke Uchida, Heisuke Iijima, Yasuhiro Hakamata, Yuka Kanda, Shin Imai, Yoshiro Otsuki, Tatsuaki Yoneda
Publikováno v:
IJU Case Reports, Vol 6, Iss 5, Pp 274-277 (2023)
Introduction Prostatic metastasis from testicular cancer is extremely rare, with only 10 reported cases, all of which were diagnosed as relapse. Herein, we report the case of a patient with concurrent testicular cancer and prostatic metastasis. Case
Externí odkaz:
https://doaj.org/article/b1b81ee1a35b40b4af86102bd7c0d8ee
Autor:
Peihang Xu, Jun Wang, Mierxiati Abudurexiti, Shengming Jin, Junlong Wu, Yijun Shen, Dingwei Ye
Publikováno v:
Frontiers in Oncology, Vol 9 (2020)
Background: Existing data on the association of metastatic sites and prognosis of patients with metastatic testicular malignancy are limited. In this study, the association of survival outcome and the prognostic value of different metastatic sites in
Externí odkaz:
https://doaj.org/article/eec882eed4f4427aaa050b4c8ef90b6e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Philippe L. Bedard, Peter Chung, Arnoud J. Templeton, Daniel Y.C. Heng, Robert J. Hamilton, Domen Ribnikar, Aaron R. Hansen, Eitan Amir, Igor Stukalin, Lynn Anson-Cartwright, Michael A.S. Jewett, Padraig Warde, Jeremy Lewin
Publikováno v:
Current Oncology, Vol 28, Iss 14, Pp 107-114 (2021)
Current Oncology
Volume 28
Issue 1
Pages 14-114
Current Oncology
Volume 28
Issue 1
Pages 14-114
We investigated the prognostic utility of pre-chemotherapy neutrophil-to-lymphocyte ratio (NLR) in patients with metastatic germ cell tumors (GCTs) undergoing first-line chemotherapy. We utilized two institutional databases to analyze the pretreatmen
Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer
Publikováno v:
Journal of Urology. 204:1242-1248
Robotic assisted retroperitoneal lymph node dissection in patients with testicular cancer is controversial. Lately, unusual recurrence patterns with adverse outcomes after robotic assisted retroperitoneal lymph node dissection have been published. In
Autor:
Alberto Briganti, Carlotta Palumbo, Elio Mazzone, Sophie Knipper, Zhe Tian, Pierre I. Karakiewicz, Shahrokh F. Shariat, Ottavio De Cobelli, Denis Soulières, Francesco Montorsi, Fred Saad, Francesco A. Mistretta
Publikováno v:
World Journal of Urology. 38:1535-1544
The International Germ Cell Consensus Classification (IGCCC) is the recommended stratification scheme for newly diagnosed metastatic seminoma (mSGCT) and non-seminoma germ cell tumor (mNSGCT) patients. However, a contemporary North-American populatio
Autor:
Eliana Piantanida, Nicola Lanzo, Bohdan Patera, Adriana Lai, Silvia Lepanto, Daniela Gallo, Tanda Maria Laura, Gaia Fazzino
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Transl Androl Urol
Treatment of testicular cancer has made significant progress in the past decades in terms of reduction of treatment-associated morbidity and preventing over-treatment. At the forefront of this progression is utilization of the da Vinci robot to perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c67ced39ecd020b4749ec83d5c9c45fb
https://europepmc.org/articles/PMC8185654/
https://europepmc.org/articles/PMC8185654/
Publikováno v:
World Journal of Clinical Oncology
BACKGROUND Testicular germ cell tumor (TGCT) is the most curable solid tumor and most common cancer among men 18-39 years. While cisplatin-based chemotherapy has significantly lengthened the survival of patients with TGCT, it is associated with a hig
Autor:
Dominic H. Tang, Jun-Min Zhou, Juan Chipollini, Andrew Leone, Richard R. Reich, Scott M. Gilbert, Wade J. Sexton
Publikováno v:
Urology Practice. 6:18-23
Introduction:We evaluated trends in insurance status, and assessed socioeconomic factors associated with clinically metastatic testicular cancer presentation and potential barriers to treat...